Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03340129
Title Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) (ABC-X)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Melanoma Institute Australia
Indications

mucosal melanoma

melanoma

skin melanoma

acral lentiginous melanoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries


No variant requirements are available.